Sulphydryl blocker induced small intestinal inflammation in rats: A new model mimicking Crohn's disease

Gut

Volumn 41, Issue 3, 1997, Pages 358-365

  Rachmilewitz, D ^a,b   Okon, E ^a   Karmeli, F ^a  

^a HEBREW UNIVERSITY   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

Apocynin; Iodoacetamide; Ketotifen; NO synthase; TEMPOL

Indexed keywords

APOCYNIN; IODOACETAMIDE; KETOPROFEN; LEUKOTRIENE B4; LEUKOTRIENE C4; MYELOPEROXIDASE; N(G) NITROARGININE METHYL ESTER; NITRIC OXIDE SYNTHASE; PROSTAGLANDIN E2; TEMPOL; THIOL DERIVATIVE; THROMBOXANE B2; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CROHN DISEASE; DRUG ANTAGONISM; ENTERITIS; ENZYME ACTIVITY; GRANULOMA; INFLAMMATION; INTESTINE ULCER; INTRAGASTRIC DRUG ADMINISTRATION; INTRAINTESTINAL DRUG ADMINISTRATION; JEJUNUM; LANGERHANS CELL; MALE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; SMALL INTESTINE; SMALL INTESTINE MUCOSA;

EID: 0030776708     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.41.3.358     Document Type: Article

References (30)

1. Elson CO, Sartor RB, Tennyson GS, Riddell RH. Experimental models of inflammatory bowel disease. Gastroenterology 1995; 109: 1344-67.
2. Miller MJS, Sadowska-Krowicka A, Chotinaruemol S, Kakkis JL, Clark DA. Amelioration of chronic ileitis by nitric oxide synthase inhibition. J Pharmacol Exp Ther 1993; 264: 11-6.
3. Yamada T, Deitch E, Specian RD, Perry MA, Sartor RB, Grisham MB. Mechanisms of acute and chronic intestinal inflammation induced by indomethacin. Inflammation 1993; 17: 641-62.
4. Sartor RB, Cromartie WJ, Powell DW, Schwab JH. Granulomatous enterocolitis induced in rats by purified bacterial cell wall fragments. Gastroenterology 1985; 89: 587-95.
5. Hammer RE, Maika SD, Richardson JA, Tang JP, Taurog JD. Spontaneous inflammatory disease in transgenic rats expressing HLA-B27 and human beta 2m: An animal model of HLA-B27-associated human disorders. Cell 1990; 63: 1099-112.
6. Kuhn R, Lohler J, Rennick D, Rajewsky K, Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993; 75: 263-74.
7. Shibata Y, Taruishi M, Ashida T. Experimental ileitis in dogs and colitis in rats with trinitrobenzene sulfonic acid-Colonoscopic and histopathologic studies. Gastroenterologica Japonica 1993; 28: 518-27.
8. Osborne MJ, Hudson M, Piasecki C, Dhillon AP, Lewis AA, Pounder RE, Wakefield AJ. Crohn's disease and anastomotic recurrence: Microvascular ischaemia and anastomotic healing in an animal model. Br J Surg 1993; 80: 226-9.
9. Rachmilewitz D, Karmeli F, Okon E. Sulphydryl blocker-induced colonic inflammation is ameliorated by inhibition of nitric oxide synthase activity. Gastroenterology 1995; 109: 98-106.
10. Bush PA, Gonzalez NE, Griscavage JM, Ignarro LJ. Nitric oxide synthase from cerebellum catalyzes the formation of equimolar quantities of nitric oxide and citrulline from L-arginine. Biochem Biophys Res Commum 1992; 185: 960-6.
11. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: Estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982; 78: 206-9.
12. Sharon P, Ligumsky M, Rachmilewitz D, Zor U. Role of prostaglandins in ulcerative colitis: Enhanced production during active disease and inhibition by sulphasalazine. Gastroenterology 1978; 65: 638-40.
13. Meyer TA, Wang J, Tiao GM, Ogle CK, Fisher JE, Hasselgren PO. Sepsis and endotoxemia stimulate intestinal interleukin-6 production. Surgery 1995; 118: 336-42.
14. Miller MJ, Zhang XJ, Gu XA, Clark D. Acute intestinal injury induced by acetic acid and casein: Prevention by intraluminal misoprostol. Gastroenterology 1991; 101: 22-30.
15. Nygard G, Anthony A, Piasecki C, Trevethick MA, Hudson M, Dhillon AP, et al. Acute indomethacin jejunal injury in the rat: Early morphological and biochemical changes. Gastroenterology 1994; 106: 567-75.
16. Meister A, Anderson ME. Glutathione. Ann Rev Biochem 1983; 52: 711-60.
17. Rachmilewitz D, Simon PL, Schwartz LW, Griswold DE, Fondacaro JD, Wasserman MA. Inflammatory mediators of experimental colitis in rats. Gastroenterology 1989; 97: 326-37.
18. Robert A, Nezamis JE, Lancaster C, Hanchar AJ. Cytoprotection by prostaglandins in rats Prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 1979; 77: 433-43.
19. Ferreira SH, Moncada S, Vane JR. Prostaglandins and signs and symptoms of inflammation. In: Robinson HJ, Vane JR, eds. Prostaglandin synthetase inhibitors. New York: Raven Press, 1974: 175-87.
20. Rachmilewitz D, Stamler JS, Bachwich D, Karmeli F, Ackerman Z, Podolsky DK. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease. Gut 1995; 36: 718-23.
21. Rachmilewitz D, Stamler JS, Karmeli F, Mullins ME, Singel D, Loscalzo J, et al. Peroxynitrite-induced rat colitis A new model of colonic inflammation. Gastroenterology 1993; 105: 1681-8.
22. Wang W, Suzuki Y, Tanigaki T, Rank DR, Raffin TA. Effect of the NADPH oxidase inhibitor apocynin on septic lung injury in guinea pigs. Am J Respir Crit Care Med 1994; 150: 1449-52.
23. t-Hart BA, Bakkr NP, Labadie RP, Simons JM. The newly developed neutrophil oxidative burst antagonist apocynin inhibits joint-swelling in rat collagen arthritis. Agents Actions Suppl 1991; 32: 179-84.
24. Rachmilewitz D, Karmeli F, Okon E, Samuni A. A novel anti-ulcerogenic stable radical prevents gastric mucosal lesions in rats. Gut 1994; 35: 1181-8.
25. Karmeli F, Eliakim R, Okon E, Samuni A, Rachmilewitz D. A stable nitroxide radical effectively decreases mucosal damage in experimental colitis. Gut 1995; 37: 386-93.
26. Karmeli F, Okon E, Rachmilewitz D. Sulphydryl blocker induced gastric damage is ameliorated by scavenging of free radicals. Gut 1996; 38: 826-31.
27. Karmeli F, Eliakim R, Okon E, Rachmilewitz D. Role of vasoactive intestinal peptide (VIP) in the pathogenesis of ethanol induced gastric mucosal damage in rats. Dig Dis Sci 1993; 38: 1210-9.
28. Eliakim R, Karmeli F, Okon E, Rachmilewitz D. Ketotifen effectively prevents mucosal damage in experimental colitis. Gut 1992; 33: 1498-503.
29. Pothoulakis C, Karmeli F, Kelly CP, Eliakim R, Joshi MA, O'Keane JO, et al. Mast cell involvement in Clostridium difficile toxin A enteritis in rat: Studies with ketotifen. Gastroenterology 1993; 105: 701-7.
30. Friedman ZY, Selinger Z, Karmeli F, Eliakim R, Rachmilewitz D. Enhanced colonic inositol phosphate generation in Crohn's disease and inhibition of its breakdown by ketotifen [abstract]. Gastroenterology 1992; 102: A623.